Bloomberg reported that the use of aspirin in fighting cancer has the potential to increase pension costs by up to $100B by extending lifespans.
Bloomberg reported that the use of aspirin in fighting cancer has the potential to increase pension costs by up to $100B by extending lifespans.
As quoted in the market news:
The pension costs for men in the U.K. could rise by 0.7 percent within 20 years if more people begin taking aspirin daily, according to a statement by Risk Management Solutions Inc. today. An increase of that magnitude across the more than $13 trillion in pension liabilities in North America and Europe would be about the same as everyone giving up smoking within a generation, the modeling firm said.